These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Jan 25, 2016
Perrigo Completes The Acquisition Of Generic Retin-A® Portfolio, Further Enhancing Rx "Extended Topicals" Strategy
- Acquires high barrier-to-entry assets that fit well within Perrigo's unique Rx extended topicals portfolio
Jan 11, 2016
- Expects full-year 2016 adjusted earnings per diluted share to be in a range of $9.50 to $10.10, an increase of 24% to 29% over 2015 adjusted earnings per diluted share guidance range of $7.65 to $7.85